ACSL1 Antibody (YA7036)

Cat. No.: HY-P87353: Data Sheet COA
SDS
User Guide for Antibodies
FAQs
Technical Support

ACSL1 Antibody (YA7036) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ACSL1.

For research use only. We do not sell to patients.

Size	Stock	Quantity
20 μL	In-stock	Estimated Time of Arrival: December 31
50 μL	In-stock	Estimated Time of Arrival: December 31
100 μL	In-stock	Estimated Time of Arrival: December 31
250 μL	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

ACSL1 Antibody (YA7036) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ACSL1.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 78 kDa;

Observed band size: 70 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human, Mouse, Rat

SwissProt ID

P33121

Immunogen

Recombinant protein within human aa 151-350 / 698.

Application &
Dilution Ratio

Application	Dilution Ratio
WB WB: Western Blot	1:1000-1:5000
IHC-P IHC-P: Immunohistochemistry-Paraffin	1:200-1:1000

Sensitivity	Endogenous	Purity	Protein A affinity purified.
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoAs for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:21242590, PubMed:22633490, PubMed:24269233). Preferentially uses palmitoleate, oleate and linoleate (PubMed:24269233). Preferentially activates arachidonate than epoxyeicosatrienoic acids (EETs) or hydroxyeicosatrienoic acids (HETEs) (By similarity)

Subcellular Localization：Mitochondrion outer membrane,Peroxisome membrane,Microsome membrane,Endoplasmic reticulum membrane

Expression：
Tissue_Specificity: Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas

Isoforms & Post-Translational Modification：P33121 has three isomers: P33121-1: 77943 Da (predicted); P33121-2: 76871 Da (predicted); P33121-3: 77907 Da (predicted).

Synonyms

ACS 1 antibody; ACS1 antibody; ACSL 1 antibody; ACSL1 antibody; ACSL1_HUMAN antibody; Acyl CoA synthetase 1 antibody; Acyl CoA synthetase long chain family member 1 antibody; Acyl-CoA synthetase 1 antibody; FACL 1 antibody; FACL 2 antibody

Documentation

Select Batch:

Data Sheet (231 KB) SDS (252 KB)

COA (205 KB)

User Guide for Antibodies (1077 KB)